Literature DB >> 22294063

Subcutaneous infection with non-mouse adapted Dengue virus D2Y98P strain induces systemic vascular leakage in AG129 mice.

Grace Kx Tan1, Jowin Kw Ng, Angeline Hy Lim, Kim Pin Yeo, Veronique Angeli, Sylvie Alonso.   

Abstract

INTRODUCTION: Dengue (DEN) is a mosquito-borne viral disease which has become an increasing economic and health burden for the tropical and subtropical world. Plasma leakage is the most life threatening condition of DEN and may lead to hypovolaemic shock if not properly managed.
MATERIALS AND METHODS: We recently reported a unique dengue virus strain (D2Y98P) which upon intraperitoneal (IP) administration to immunocompromised mice led to systemic viral dissemination, intestine damage, liver dysfunction, and increased vascular permeability, hallmarks of severe DEN in patients (Tan et al, PLoS Negl Trop Dis 2010;4:e672).
RESULTS: Here we report the clinical manifestations and features observed in mice subcutaneously (SC) infected with D2Y98P, which is a route of administration closer to natural infection. Similar to the IP route, increased vascular permeability, intestine damage, liver dysfunction, transient lymphopenia (but no thrombocytopenia) were observed in the SC infected mice. Furthermore, the SC route of infection was found more potent than the IP route whereby higher viral titers and earlier time-of-death rates were measured. In addition, various staining approaches revealed structurally intact blood vessels in the moribund animals despite pronounced systemic vascular leakage, as reported in dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) patients. Interestingly, measurement of soluble mediators involved in vascular permeability indicated that vascular leakage may occur at an early stage of the disease, as proposed in DEN patients.
CONCLUSION: We believe that this novel mouse model of DEN-associated vascular leakage will contribute to a better understanding of DEN pathogenesis and represents a relevant platform for testing novel therapeutic treatments and interventions.

Entities:  

Mesh:

Year:  2011        PMID: 22294063

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  13 in total

Review 1.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

Review 2.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

3.  A lethal model of disseminated dengue virus type 1 infection in AG129 mice.

Authors:  Gregg N Milligan; Vanessa V Sarathy; Mellodee M White; M Banks Greenberg; Gerald A Campbell; Richard B Pyles; Alan D T Barrett; Nigel Bourne
Journal:  J Gen Virol       Date:  2017-09-27       Impact factor: 3.891

Review 4.  Ideal Criteria for Accurate Mouse Models of Vector-Borne Diseases with Emphasis on Scrub Typhus and Dengue.

Authors:  Vanessa V Sarathy; David H Walker
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

5.  A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.

Authors:  Gregg N Milligan; Vanessa V Sarathy; Ernesto Infante; Li Li; Gerald A Campbell; P Robert Beatty; Eva Harris; Alan D T Barrett; Nigel Bourne
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

6.  Development of a transmission model for dengue virus.

Authors:  Rebecca C Christofferson; Michael K McCracken; Ann-Marie Johnson; Daniel M Chisenhall; Christopher N Mores
Journal:  Virol J       Date:  2013-04-23       Impact factor: 4.099

7.  Hypertonic saline reduces vascular leakage in a mouse model of severe dengue.

Authors:  Grace Kai Xin Tan; Jowin Kai Wei Ng; Kar Wai Tan; Veronique Angeli; Shabbir Moochhala; Eng Eong Ooi; Sylvie Alonso
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

8.  First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies.

Authors:  Jowin Kai Wei Ng; Summer Lixin Zhang; Hwee Cheng Tan; Benedict Yan; Julia Maria Martinez; Wei Yu Tan; Jian Hang Lam; Grace Kai Xin Tan; Eng Eong Ooi; Sylvie Alonso
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

9.  Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage.

Authors:  Julia María Martínez Gómez; Li Ching Ong; Jian Hang Lam; Siti Amanlina Binte Aman; Eshele Anak Libau; Pei Xuan Lee; Ashley L St John; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2016-03-23

10.  Stem Cell Therapy in Dengue Virus-Infected BALB/C Mice Improves Hepatic Injury.

Authors:  S Sakinah; Sivan Padma Priya; Pooi Ling Mok; Rusheni Munisvaradass; Seoh Wei Teh; Zhong Sun; Badr Alzahrani; Faizal Abu Bakar; Hui-Yee Chee; Rukman Awang Hamat; Guozhong He; Chenglong Xiong; Narcisse Joseph; Jia Bei Tong; Xiaoyun Wu; Mahendran Maniam; Antony V Samrot; Akon Higuchi; S Suresh Kumar
Journal:  Front Cell Dev Biol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.